Your session is about to expire
← Back to Search
Virtual Physical Rehabilitation for Long COVID
N/A
Waitlist Available
Led By Jean Bourbeau, MD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patients (18+ years old) who have had a confirmed or probable COVID-19 infection and who have self-reported persisting symptoms of either reduced mobility, muscle weakness, dyspnea, or fatigue
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 8 (up to 1 week), and at 6 months.
Awards & highlights
Study Summary
This trial will test if a home-based physical rehabilitation program can help improve mobility for people who have been hospitalized for COVID-19.
Who is the study for?
This trial is for adults over 18 who've had COVID-19 and are experiencing ongoing symptoms like reduced mobility, muscle weakness, breathlessness, or fatigue. They must be able to use videoconferencing technology for virtual rehab sessions.Check my eligibility
What is being tested?
The study is testing if a virtual home-based physical rehabilitation program can help improve the functional mobility of patients with long COVID better than the usual outpatient care they receive.See study design
What are the potential side effects?
Since this intervention involves physical rehabilitation exercises done virtually, potential side effects may include typical exercise-related discomforts such as muscle soreness or fatigue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18 and still feel weak or tired from COVID-19.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, week 8 (up to 1 week), and at 6 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 8 (up to 1 week), and at 6 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in the basic mobility domain of the Activity Measure for Post-Acute Care (AM-PAC)
Secondary outcome measures
Change in anxiety and depression
Change in cognitive function
Change in dyspnea
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual home-based rehabilitation plus usual outpatient careExperimental Treatment1 Intervention
An 8-week home-based virtual rehabilitation program consisting of exercises and education plus usual care.
Group II: Usual outpatient careActive Control1 Intervention
The control group will receive usual outpatient care which consists of any medical outpatient follow-up visits. The participants will receive a set of written generic instructions on how to manage symptoms and engage in physical activity after critical illness.
Find a Location
Who is running the clinical trial?
Santé WillKin (WillKin Health)UNKNOWN
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,452,581 Total Patients Enrolled
31 Trials studying COVID-19
361,742 Patients Enrolled for COVID-19
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
442 Previous Clinical Trials
159,042 Total Patients Enrolled
13 Trials studying COVID-19
5,979 Patients Enrolled for COVID-19
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot speak or understand English or French.I can work with a research assistant online or have someone to help me do so.I have a heart, muscle, or nerve condition that makes physical therapy unsafe.I am over 18 and still feel weak or tired from COVID-19.I can use video calls for appointments, either by myself or with help.
Research Study Groups:
This trial has the following groups:- Group 1: Virtual home-based rehabilitation plus usual outpatient care
- Group 2: Usual outpatient care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current enrollment tally for this investigation?
"Affirmative. Clinicaltrials.gov displays that this medical investigation is actively searching for participants, which was initially published on August 1st 2022 and most recently updated November 3rd 2022. 132 individuals are desired at 2 sites of research."
Answered by AI
Are there any opportunities for participants to join this experiment?
"According to the most recent information posted on clinicaltrials.gov, this research is actively seeking out participants. The trial was first made available for enrollment on August 1st 2022 and a subsequent update occurred November 3rd of that same year."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger